Clinical Trial Update: Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting on the efficacy and safety of a triple combination therapy (valsartan, hydrochlorothiazide, and amlodipine) for hyperten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• DIOVAN (valsartan)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• NORVASC (amlodipine besylate)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED